6th Annual Next Generation Sequencing USA Congress (Delivered Digitally)

6th Annual NextGeneration Sequencing USA Congress logo
7 April, 2020 - 8 April, 2020

Hyatt Regency Boston, One Avenue de Lafayette, Boston, Massachusetts, United States, 02111

General Information

In light of the current COVID-19 situation, Oxford Global have made the decision to deliver NextGen Omics US as a fully digital event. The dates and timings for the event will continue as normal, however presentations will be hosted virtually.

350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

80+ case studies, solution & technology presentations & 2 interactive workshops.

07 April 2019 – Day One

  • Discussion Workshop: Accuracy, cost and coverage of short and long read sequencing
  • Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 1)

08 April 2019 – Day Two

  • Future Directions In Long Read Sequencing For Human Genomes And De Novo Studies (part 2)

View Agenda: http://bit.ly/2QijaD2

For more information and to register please visit the event webpage.


Jane Wilkinson, Senior Director, Broad Genomics Alliance Management, Broad Institute at Harvard & Massachusetts Institute of Technology

Cynthia Morton, Director of Cytogenetics, Harvard University

Chia-Lin Wei, Director of Genome Technology, The Jackson Laboratory

Suzanne Leal, Sergievsky Family Professor of Neurological Sciences, Director – Center for Statistical Genetic – Columbia University

Rong Mao, Professor of Pathology, University of Utah School of Medicine, Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Stuart A. Scott, Associate Professor, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Division Head, Pharmacogenomics, Director, Cytogenetics and Cytogenomics